Home LiteratureArticle Details
PMID: 18256261 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural

A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.

Miller JA, Oldham MC, Geschwind DH

Abstract

Alzheimer's disease (AD) is a debilitating neurodegenerative disorder affecting millions of elderly individuals worldwide. Advances in the genetics of AD have led to new levels of understanding and treatment opportunities. Here, we used a systems biology approach based on weighted gene coexpression network analysis to determine transcriptional networks in AD. This method permits a higher order depiction of gene expression relationships and identifies modules of coexpressed genes that are functionally related, rather than producing massive gene lists. Using this framework, we characterized the transcriptional network in AD, identifying 12 distinct modules related to synaptic and metabolic processes, immune response, and white matter, nine of which were related to disease progression. We further examined the association of gene expression changes with progression of AD and normal aging, and were able to compare functional modules of genes defined in both conditions. Two biologically relevant modules were conserved between AD and aging, one related to mitochondrial processes such as energy metabolism, and the other related to synaptic plasticity. We also identified several genes that were central, or hub, genes in both aging and AD, including the highly abundant signaling molecule 14.3.3 zeta (YWHAZ), whose role in AD and aging is uncharacterized. Finally, we found that presenilin 1 (PSEN1) is highly coexpressed with canonical myelin proteins, suggesting a role for PSEN1 in aspects of glial-neuronal interactions related to neurodegenerative processes.

MeSH Terms
Adult Aged Aged, 80 and over Aging/genetics,metabolism Alzheimer Disease/genetics,pathology,physiopathology Gene Expression Profiling/methods Hippocampus/pathology,physiology Humans Middle Aged Presenilin-1/biosynthesis,genetics,physiology Systems Biology/methods Transcription, Genetic/genetics
Chemicals
PSEN1 protein, human Presenilin-1
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Miller Jeremy A
Center for Neurobehavioral Genetics, University of California, Los Angeles, Los Angeles, California 90095-1769, USA.
Oldham Michael C
Geschwind Daniel H
References (57)
57 references, click to expand
  1. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
    Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10540-3 PMID: 1683703
  2. Age-related neuropathology, cognitive decline, and Alzheimer's disease.
    Ageing Res Rev. 2006 Feb;5(1):1-13 PMID: 16084778
  3. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.
    Neurochem Int. 2007 Jan;50(1):12-38 PMID: 16973241
  4. Lethality and centrality in protein networks.
    Nature. 2001 May 3;411(6833):41-2 PMID: 11333967
  5. A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration.
    Neuron. 2006 Sep 7;51(5):549-60 PMID: 16950154
  6. Expression monitoring by hybridization to high-density oligonucleotide arrays.
    Nat Biotechnol. 1996 Dec;14(13):1675-80 PMID: 9634850
  7. Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice.
    Neuromolecular Med. 2003;3(1):53-64 PMID: 12665676
  8. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo.
    J Neurosci. 2006 Oct 11;26(41):10536-41 PMID: 17035538
  9. Coexpression analysis of human genes across many microarray data sets.
    Genome Res. 2004 Jun;14(6):1085-94 PMID: 15173114
  10. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
    J Psychiatr Res. 1975 Nov;12(3):189-98 PMID: 1202204
  11. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.
    Ann Neurol. 1999 Mar;45(3):358-68 PMID: 10072051
  12. Imaging-guided microarray: isolating molecular profiles that dissociate Alzheimer's disease from normal aging.
    Ann N Y Acad Sci. 2007 Feb;1097:225-38 PMID: 17413025
  13. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.
    Neurology. 2003 May 13;60(9):1495-500 PMID: 12743238
  14. Aging, metabolism, and Alzheimer disease: review and hypotheses.
    Exp Neurol. 1997 Jan;143(1):82-102 PMID: 9000448
  15. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.
    Neuron. 1996 Nov;17(5):1005-13 PMID: 8938131
  16. Neuropathological stageing of Alzheimer-related changes.
    Acta Neuropathol. 1991;82(4):239-59 PMID: 1759558
  17. DNA-microarray analysis of brain cancer: molecular classification for therapy.
    Nat Rev Neurosci. 2004 Oct;5(10):782-92 PMID: 15378038
  18. VisANT: an online visualization and analysis tool for biological interaction data.
    BMC Bioinformatics. 2004 Feb 19;5:17 PMID: 15028117
  19. Progress in the use of microarray technology to study the neurobiology of disease.
    Nat Neurosci. 2004 May;7(5):434-9 PMID: 15114354
  20. Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain.
    Neurobiol Aging. 2000 Nov-Dec;21(6):783-96 PMID: 11124422
  21. Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.
    Electrophoresis. 2001 Jan;22(1):172-9 PMID: 11197169
  22. Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein.
    J Biol Chem. 2003 Jan 31;278(5):3446-54 PMID: 12435726
  23. Neurodegeneration and plasticity.
    Int J Dev Neurosci. 2004 Nov;22(7):507-14 PMID: 15465280
  24. Cdk5 deregulation in the pathogenesis of Alzheimer's disease.
    Trends Mol Med. 2004 Sep;10(9):452-8 PMID: 15350898
  25. Network biology: understanding the cell's functional organization.
    Nat Rev Genet. 2004 Feb;5(2):101-13 PMID: 14735121
  26. Conservation and evolution of gene coexpression networks in human and chimpanzee brains.
    Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17973-8 PMID: 17101986
  27. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
    Neuron. 2003 Oct 30;40(3):471-83 PMID: 14642273
  28. Content-rich biological network constructed by mining PubMed abstracts.
    BMC Bioinformatics. 2004 Oct 08;5:147 PMID: 15473905
  29. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling.
    Neurobiol Dis. 2006 Mar;21(3):618-25 PMID: 16257224
  30. WebGestalt: an integrated system for exploring gene sets in various biological contexts.
    Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W741-8 PMID: 15980575
  31. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target.
    Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17402-7 PMID: 17090670
  32. A gene expression profile of Alzheimer's disease.
    DNA Cell Biol. 2001 Nov;20(11):683-95 PMID: 11788046
  33. Quantitative monitoring of gene expression patterns with a complementary DNA microarray.
    Science. 1995 Oct 20;270(5235):467-70 PMID: 7569999
  34. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles.
    Neuron. 1999 Nov;24(3):521-9 PMID: 10595506
  35. Hierarchical organization of modularity in metabolic networks.
    Science. 2002 Aug 30;297(5586):1551-5 PMID: 12202830
  36. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.
    Neurobiol Aging. 2004 Jan;25(1):5-18; author reply 49-62 PMID: 14675724
  37. The role of the metabolic lesion in Alzheimer's disease.
    J Alzheimers Dis. 2002 Jun;4(3):225-32 PMID: 12226541
  38. 14-3-3 proteins: a historic overview.
    Semin Cancer Biol. 2006 Jun;16(3):162-72 PMID: 16678438
  39. Network neighborhood analysis with the multi-node topological overlap measure.
    Bioinformatics. 2007 Jan 15;23(2):222-31 PMID: 17110366
  40. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
    Nature. 2006 Oct 19;443(7113):787-95 PMID: 17051205
  41. Analysis of matched mRNA measurements from two different microarray technologies.
    Bioinformatics. 2002 Mar;18(3):405-12 PMID: 11934739
  42. Aging of the brain, entropy, and Alzheimer disease.
    Neurology. 2006 Oct 24;67(8):1340-52 PMID: 17060558
  43. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes.
    Bioinformatics. 2001 Jun;17(6):509-19 PMID: 11395427
  44. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis.
    Acta Neuropathol. 1996 Aug;92(2):197-201 PMID: 8841666
  45. Mitochondria take center stage in aging and neurodegeneration.
    Ann Neurol. 2005 Oct;58(4):495-505 PMID: 16178023
  46. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.
    Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2173-8 PMID: 14769913
  47. Identifying biological themes within lists of genes with EASE.
    Genome Biol. 2003;4(10):R70 PMID: 14519205
  48. Preferred analysis methods for Affymetrix GeneChips revealed by a wholly defined control dataset.
    Genome Biol. 2005;6(2):R16 PMID: 15693945
  49. A general framework for weighted gene co-expression network analysis.
    Stat Appl Genet Mol Biol. 2005;4:Article17 PMID: 16646834
  50. Gene regulation and DNA damage in the ageing human brain.
    Nature. 2004 Jun 24;429(6994):883-91 PMID: 15190254
  51. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
    J Neurosci Res. 2002 Nov 1;70(3):462-73 PMID: 12391607
  52. Oxidative damage is the earliest event in Alzheimer disease.
    J Neuropathol Exp Neurol. 2001 Aug;60(8):759-67 PMID: 11487050
  53. Cognitive decline strongly correlates with cortical atrophy in Alzheimer's dementia.
    Neurobiol Aging. 1998 Sep-Oct;19(5):371-7 PMID: 9880038
  54. Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg?
    Neuron. 2003 Oct 30;40(3):457-60 PMID: 14642270
  55. The aging brain.
    Clin Geriatr Med. 1985 Feb;1(1):61-94 PMID: 3006903
  56. Model-guided microarray implicates the retromer complex in Alzheimer's disease.
    Ann Neurol. 2005 Dec;58(6):909-19 PMID: 16315276
  57. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study.
    Schizophr Res. 2002 Nov 1;58(1):11-20 PMID: 12363385
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2008-02-06
Pages
1410-20
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC2902235
Subset
IM
Grants
NIMH NIH HHS · T32 MH073526 · United States
NIMH NIH HHS · T32 MH073526-01A1 · United States
NIA NIH HHS · U01 AG016976 · United States
NIA NIH HHS · F31 AG031649-01 · United States
NIA NIH HHS · R01 AG026938 · United States
NIA NIH HHS · R01 AG026938-01 · United States
NIA NIH HHS · R01 AG26938 · United States
NIMH NIH HHS · T32MH073526-01A1 · United States
NIA NIH HHS · F31 AG031649 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]